Page last updated: 2024-08-24

3-iodobenzylguanidine and Goldblatt Syndrome

3-iodobenzylguanidine has been researched along with Goldblatt Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caballero, C; Cordero, J; Crespo, A; Díez, L; Rioja, M1
Abe, I; Fujishima, M; Fujishima, S; Kagiyama, S; Kaseda, S; Kuwabara, Y; Ohmori, S; Ohya, Y; Onaka, U; Sasaki, M1

Trials

1 trial(s) available for 3-iodobenzylguanidine and Goldblatt Syndrome

ArticleYear
Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2001, Volume: 23, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Echocardiography; Female; Heart; Humans; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2001

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Goldblatt Syndrome

ArticleYear
[Congenital cyanotic heart disease and peripheral neurogenic tumor].
    Revista espanola de medicina nuclear, 1999, Volume: 18, Issue:1

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Chronic Disease; Dextrocardia; Epilepsy, Tonic-Clonic; Fatal Outcome; Heart Defects, Congenital; Humans; Hypertension; Hypertension, Renovascular; Hypoxia; Male; Metanephrine; Paraganglioma; Pentetic Acid; Pulmonary Edema; Renal Artery; Situs Inversus; Tomography, Emission-Computed, Single-Photon

1999